The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | Webcast | Endocrine functions of the bone and their potential contributions to systemic CKD complications

Endocrine functions of the bone and their potential contributions to systemic CKD complications